Treatment of Angioblastoma with Recombinant Interferon‐α2
- 28 June 1995
- journal article
- Published by Wiley in Pediatric Dermatology
- Vol. 12 (2) , 184-186
- https://doi.org/10.1111/j.1525-1470.1995.tb00150.x
Abstract
Interferon‐α2 has been used successfully to treat anglomatous lesions such as Kaposi sarcoma and life‐threatening hemangiomas, possibly by its antlangiogenetic activity. We report the successful use of this agent in a child with an angloblastoma of the right leg.Keywords
This publication has 11 references indexed in Scilit:
- The therapeutic effect of intralesional interferon in classical Kaposi's sarcomaBritish Journal of Dermatology, 1993
- Interferon Alfa-2a Therapy for Life-Threatening Hemangiomas of InfancyNew England Journal of Medicine, 1992
- Angioblastoma (Nakagawa)-is it the same as tufted angioma?Clinical and Experimental Dermatology, 1991
- TREATMENT OF HAEMANGIOENDOTHELIOMAS WITH ALPHA INTERFERONThe Lancet, 1989
- Treatment of Pulmonary Hemangiomatosis with Recombinant Interferon Alfa-2aNew England Journal of Medicine, 1989
- Tufted angioma (angioblastoma)Journal of the American Academy of Dermatology, 1989
- Acquired Tufted AngiomaThe American Journal of Dermatopathology, 1986
- The antiproliferative effect of interferon and the mitogenic activity of growth factors are independent cell cycle eventsExperimental Cell Research, 1985
- ULTRASTRUCTURE OF SO-CALLED ANGIOBLASTOMA OF THE SKIN BEFORE AND AFTER SOFT X-RAY THERAPYThe Journal of Dermatology, 1981
- Malignant vascular tumours*Clinical and Experimental Dermatology, 1976